𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B

✍ Scribed by Mario Rizzetto; Nicholas C. Tassopoulos; Robert D. Goldin; Rafael Esteban; Teresa Santantonio; E. Jenny Heathcote; Marco Lagget; Namrata K. Taak; Mary A. Woessner; Stephen D. Gardner

Book ID
116650523
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
175 KB
Volume
42
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy of lamivudine in HBeAg-negative
Efficacy of lamivudine in HBeAg-negative chronic hepatitis B
✍ Mario Rizzetto πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 136 KB

## Abstract Hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B results from infection with hepatitis B virus mutants unable to produce HBeAg. It accounts for 7–30% of patients with chronic hepatitis B virus (HBV) worldwide, with the highest rates reported for Mediterranean Europe and Asia.